Latest Product Innovation News

Merino & Co reported a transformative quarter marked by operational upgrades, new product launches, and the integration of cryptocurrency payments, ending with a robust cash position to fuel future growth.

EOS is midway through a strategic turnaround, divesting non-core assets and strengthening its balance sheet while advancing cutting-edge counter-drone, high energy laser weapons, and space control technologies amid robust global demand.

Eneco Refresh Limited reports solid 8% year-to-date revenue growth for Q3 FY2025, underpinned by gains in its water and plastics segments and improved cash flow.

Elixinol Wellness reported a 13.7% year-on-year revenue increase in Q1 FY25, despite a softer quarter compared to record Q4, with ecommerce momentum and strategic initiatives setting the stage for margin recovery and growth in H2.

Atomos Limited reported a $2.3 million operating cash outflow in Q3 FY25 amid seasonal softness and tariff challenges, while announcing a leadership change and a bold expansion into new product categories beyond its core monitor-recorder business.

Pointerra Limited’s Q3 FY25 results reveal delayed invoicing milestones pushed into Q4, yet strong progress across multiple sectors and promising product development underpin an optimistic cashflow outlook.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Wide Open Agriculture has inked an exclusive 18-month distribution agreement with Univar Solutions China to market its lupin protein products, marking a strategic push into the lucrative Chinese plant-based protein sector.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

BirdDog Technology reported a slight 4.1% decline in Q3 FY25 sales to A$3.6 million while progressing strongly on its next-generation product roadmap and implementing significant cost reductions.

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

Lark Distilling Co. reported a robust Q3FY25 with net sales rising 31% to $4.3 million, driven by growth in travel retail, ecommerce, and exclusive whisky releases. The company also progressed its Pontville distillery redevelopment and maintained positive operating cash flow.